TI
KERX

Turner Investments’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Turner Investments’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-38,790
Closed -$494K – 436
2015
Q1 		$494K Sell
38,790
-98,660
-72% -$1.27M 0.09% 228
2014
Q4 		$1.95M Sell
137,450
-354,040
-72% -$5.49M 0.23% 140
2014
Q3 		$6.76M Buy
491,490
+361,170
+277% +$5.53M 0.41% 65
2014
Q2 		$2M Buy
130,320
+6,600
+5% +$93.6K 0.09% 285
2014
Q1 		$2.11M Buy
123,720
+31,000
+33% +$468K 0.06% 323
2013
Q4 		$1.2M Buy
+92,720
New +$1.11M 0.02% 465

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Turner Investments's KERX Position: Q2 2015 in Review

Turner Investments sold out of Keryx Biopharmaceuticals Inc (KERX) in Q2 2015, closing a stake of 38,790 shares — an estimated $494K sold.

Turner Investments first reported a position in KERX in Q4 2013 and held it in 6 quarters. The position peaked at $6.76M in Q3 2014. 153 funds tracked by Wall St. Rank hold KERX as of Q2 2015.

  • Turner Investments reported no remaining Keryx Biopharmaceuticals Inc position as of Q2 2015 after selling out during the quarter.
  • Turner Investments sold 38,790 Keryx Biopharmaceuticals Inc shares in Q2 2015, an estimated $494K.
  • Turner Investments first reported a position in Keryx Biopharmaceuticals Inc in Q4 2013 and held it in 6 quarters.
  • Turner Investments's Keryx Biopharmaceuticals Inc position peaked at $6.76M in Q3 2014.
  • 153 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q2 2015.

Based on Turner Investments's 13F filing for Q2 2015, filed 12 Aug 2015.